All In Biotech

Drug Trial Radar · NCT07213674

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 750 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

750

Planned (sponsor's estimate)

Start

Nov 28, 2025

Primary completion

Jan 7, 2030

Study completion Aug 30, 2032

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Oct 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (docetaxel, cabazitaxel, or abiraterone).

Conditions

  • Metastatic Castration-resistant Prostate Cancer

Interventions

  • XaluritamigDrug

    Xaluritamig will be administered IV.

  • Abiraterone acetateDrug

    Abiraterone acetate will be administered orally.

  • DocetaxelDrug

    Docetaxel will be administered IV.

  • CabazitaxelDrug

    Cabazitaxel will be administered IV.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. OSTime frame: Up to approximately 51 months

Locations

159 sites in 18 countries. Site status is shown where the registry gives one.

  • City of Hope Cancer Center Phoenix

    Goodyear, Arizona · Recruiting

  • University of Arizona Cancer Center

    Tucson, Arizona · Recruiting

  • City of Hope National Medical Center

    Duarte, California · Recruiting

  • City of Hope Orange County Lennar Foundation Cancer Center

    Duarte, California · Recruiting

  • Providence Saint Jude Medical Center

    Fullerton, California · Recruiting

  • University of California Los Angeles

    Los Angeles, California · Recruiting

  • University of California Irvine

    Orange, California · Recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • Providence Saint Johns Health Center

    Santa Monica, California · Recruiting

  • Rocky Mountain Cancer Centers

    Denver, Colorado · Recruiting

  • Hartford HealthCare Cancer Institute at Hartford Hospital

    Hartford, Connecticut · Recruiting

  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center

    Newark, Delaware · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • City of Hope Atlanta

    Newnan, Georgia · Recruiting

  • University of Illinois Chicago

    Chicago, Illinois · Recruiting

  • Cancer Care Specialists of Illinois

    Decatur, Illinois · Recruiting

  • Midwestern Regional Medical Center dba City of Hope Chicago

    Zion, Illinois · Recruiting

  • University of Kansas Medical Center

    Westwood, Kansas · Recruiting

  • University of Louisville Health - James Graham Brown Cancer Center

    Louisville, Kentucky · Recruiting

  • Norton Cancer Institute

    Louisville, Kentucky · Terminated

  • University of Maryland Greenebaum Cancer Center

    Baltimore, Maryland · Recruiting

  • Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center

    Baltimore, Maryland · Recruiting

  • Barbara Ann Karmanos Cancer Institute

    Lansing, Michigan · Recruiting

  • Minnesota Oncology Hematology PA

    Minneapolis, Minnesota · Recruiting

  • University of Minnesota Medical Center Fairview

    Minneapolis, Minnesota · Recruiting

  • Hematology Oncology Association of Central New York

    East Syracuse, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Oncology Hematology Care Incorporated

    Cincinnati, Ohio · Recruiting

  • The Ohio State University

    Columbus, Ohio · Recruiting

  • Dayton Physicians LLC Dayton

    Dayton, Ohio · Recruiting

  • Hightower Clinical

    Oklahoma City, Oklahoma · Recruiting

  • Oregon Oncology Specialists

    Salem, Oregon · Recruiting

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania · Recruiting

  • South Texas Accelerated Research Therapeutics - Carolinas

    Myrtle Beach, South Carolina · Recruiting

  • Sarah Cannon Research Institute Oncology Partners

    Nashville, Tennessee · Recruiting

  • United States Oncology Regulatory Affairs Corporate Office

    Nashville, Tennessee · Recruiting

  • The Center for Cancer and Blood Disorders

    Arlington, Texas · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Renovatio Clinical

    Houston, Texas · Recruiting

  • Texas Oncology - Northeast Texas

    Tyler, Texas · Recruiting

Showing 40 of 159 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.